The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Agios Pharmaceuticals Inc shares valued at $124,634 were sold by Jones Cecilia on Sep 26 ’24. At $49.03 per share, Jones Cecilia sold 2,542 shares. The insider’s holdings dropped to 20,158 shares worth approximately $0.84 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Goff Brian sold 11,091 shares, netting a total of over 474,140 in proceeds. Following the sale of shares at $42.75 each, the insider now holds 78,792 shares.
Before that, Goff Brian had added 11,091 shares to its account. In a trade valued at $474,184, the Officer bought Agios Pharmaceuticals Inc shares for $42.75 each.
As published in a research note from Leerink Partners on September 27, 2024, Agios Pharmaceuticals Inc [AGIO] has been rated down from an Outperform to a Market perform and the price target has been revised to $56 from $60. Analysts at Cantor Fitzgerald started covering the stock with ‘”an Overweight”‘ outlook in a report released in early February. As of February 03, 2023, Piper Sandler has initiated its “an Overweight” rating for AGIO. Earlier on November 17, 2022, Goldman upgraded its rating. Their new recommendation was “a Neutral” for AGIO stock which previously was a “a Sell”.
Analyzing AGIO Stock Performance
During the last five days, there has been a drop of approximately -14.77%. Over the course of the year, Agios Pharmaceuticals Inc shares have jumped approximately 87.65%. Shares of the company reached a 52-week high of $53.28 on 09/26/24 and a 52-week low of $20.96 on 01/19/24. A 50-day SMA is recorded $45.38, while a 200-day SMA reached $35.65. Nevertheless, trading volume fell to 0.77 million shares from 0.59 million shares the previous day.
Support And Resistance Levels for Agios Pharmaceuticals Inc (AGIO)
According to the 24-hour chart, there is a support level at 41.15, which, if violated, would cause prices to drop to 40.52. In the upper region, resistance lies at 42.48. The next price resistance is at 43.18. RSI (Relative Strength Index) is 37.42 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.89, which suggests the price will decrease in the coming days. Percent R is at 95.20%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
